These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 17900820
1. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Mahasittiwat P, Mizoe JE, Hasegawa A, Ishikawa H, Yoshikawa K, Mizuno H, Yanagi T, Takagi R, Pattaranutaporn P, Tsujii H. Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):515-22. PubMed ID: 17900820 [Abstract] [Full Text] [Related]
2. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. Matsuo M, Miwa K, Tanaka O, Shinoda J, Nishibori H, Tsuge Y, Yano H, Iwama T, Hayashi S, Hoshi H, Yamada J, Kanematsu M, Aoyama H. Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):83-9. PubMed ID: 21095072 [Abstract] [Full Text] [Related]
3. Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma. Navarria P, Reggiori G, Pessina F, Ascolese AM, Tomatis S, Mancosu P, Lobefalo F, Clerici E, Lopci E, Bizzi A, Grimaldi M, Chiti A, Simonelli M, Santoro A, Bello L, Scorsetti M. Radiother Oncol; 2014 Sep 01; 112(3):425-9. PubMed ID: 25308182 [Abstract] [Full Text] [Related]
4. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Grosu AL, Weber WA, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M, Molls M. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):64-74. PubMed ID: 16111573 [Abstract] [Full Text] [Related]
5. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. Li FM, Nie Q, Wang RM, Chang SM, Zhao WR, Zhu Q, Liang YK, Yang P, Zhang J, Jia HW, Fang HH. Nucl Med Biol; 2012 Apr 01; 39(3):437-42. PubMed ID: 22172386 [Abstract] [Full Text] [Related]
6. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A. Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1100-6. PubMed ID: 24161427 [Abstract] [Full Text] [Related]
7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):511-9. PubMed ID: 16168843 [Abstract] [Full Text] [Related]
8. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas. Gumprecht H, Grosu AL, Souvatsoglou M, Dzewas B, Weber WA, Lumenta CB. Zentralbl Neurochir; 2007 Feb 01; 68(1):19-23. PubMed ID: 17487804 [Abstract] [Full Text] [Related]
9. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors. Schinkelshoek M, Lopci E, Clerici E, Alongi F, Mancosu P, Rodari M, Navarria P, van der Hiel B, Scorsetti M, Chiti A. Tumori; 2014 Feb 01; 100(6):636-44. PubMed ID: 25688497 [Abstract] [Full Text] [Related]
10. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgård S, Kulmala J, Teräs M, Minn H. Int J Radiat Oncol Biol Phys; 2000 Aug 01; 48(1):43-52. PubMed ID: 10924970 [Abstract] [Full Text] [Related]
11. Target definition by C11-methionine-PET for the radiotherapy of brain metastases. Matsuo M, Miwa K, Shinoda J, Kako N, Nishibori H, Sakurai K, Yano H, Iwama T, Kanematsu M. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):714-22. PubMed ID: 19095373 [Abstract] [Full Text] [Related]
12. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy. Hirata T, Kinoshita M, Tamari K, Seo Y, Suzuki O, Wakai N, Achiha T, Umehara T, Arita H, Kagawa N, Kanemura Y, Shimosegawa E, Hashimoto N, Hatazawa J, Kishima H, Teshima T, Ogawa K. J Neurosurg; 2019 Sep 01; 131(3):676-686. PubMed ID: 30239314 [Abstract] [Full Text] [Related]
13. Is there any additional benefit of 68Ga-PSMA PET on radiotherapy target volume definition in patients with glioblastoma? Şahin M, Akgun E, Sirolu S, Can G, Sayman HB, Oner Dincbas F. Br J Radiol; 2022 Oct 01; 95(1139):20220049. PubMed ID: 35993417 [Abstract] [Full Text] [Related]
14. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma. Hayes AR, Jayamanne D, Hsiao E, Schembri GP, Bailey DL, Roach PJ, Khasraw M, Newey A, Wheeler HR, Back M. Pract Radiat Oncol; 2018 Oct 01; 8(4):230-238. PubMed ID: 29730279 [Abstract] [Full Text] [Related]
15. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours. Cicuendez M, Lorenzo-Bosquet C, Cuberas-Borrós G, Martinez-Ricarte F, Cordero E, Martinez-Saez E, Castell-Conesa J, Sahuquillo J. Clin Neurol Neurosurg; 2015 Dec 01; 139():328-33. PubMed ID: 26588352 [Abstract] [Full Text] [Related]
17. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. Nariai T, Ishiwata K, Kimura Y, Inaji M, Momose T, Yamamoto T, Matsumura A, Ishii K, Ohno K. Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S348-50. PubMed ID: 19375930 [Abstract] [Full Text] [Related]
19. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion. Krengli M, Loi G, Sacchetti G, Manfredda I, Gambaro G, Brambilla M, Carriero A, Inglese E. Strahlenther Onkol; 2007 Dec 01; 183(12):689-94. PubMed ID: 18040614 [Abstract] [Full Text] [Related]